Cistiprost prostate bladder supplement 20 tablets

Cistiprost Food supplement.
It is a valid support towards the functional protection of the prostate and bladder.
Lapacho (Tabebuia Avellanedae)
Of this plant the intermediate part of the bark is used to treat various ailments. The antiseptic activity of the Lapacho extract (Tabebuia Avellanedae) and its 18 components has shown inhibitory properties towards gram-positive bacteria (staphylococci, streptococci), and also towards gram-negative (brucella) and fungi (candida albicans). The active ingredients of Lapacho (Tab. Av.) Interfere with the energy and enzymatic production of pathogenic microorganisms and viruses, causing their death. It has also been found that "lapachol" and the other components (quinones, naphthoquinones and anthraquinones) are able to exert immunostimulating effects on granulocytes, macrophages and lymphocytes. Furthermore, Lapacho exerts an antioxidant effect through “carnasol”, one of its most active constituents, which inhibits free radicals and inflammatory leukotrienes. As reported, Lapacho (Tab. Av.) Is of particular utility and help in the treatment of acute and chronic prostatitis and benign prostatic hypertrophy.
"Crystals" lycopene
Carotenoid present particularly in tomatoes and in various species of berries, vegetables and mushrooms, it is one of the most powerful antioxidants reducing the risk of both chronic inflammation of the prostate. Accumulating, as well as in the prostate, in the adrenal glands, in the testicles, in the liver, it acts against cell proliferation and aging, which are possible causes of many diseases. A noteworthy feature is given by the type of Lycopene used in Cistiprost. It derives from absolutely vegetable extraction, coming from a fungus (Blakeslea Trispora), a method protected by a world patent, which guarantees stability for over 24 months, bioavailability, dissolution in cold water (CWD) and comfortable storage mode.
MSM (methylsufonylmethane)
It occurs naturally in animal and plant organisms and in the human body, particularly in the blood and urine. MSM has a strong pain relieving power as well as diuretic, antibacterial and antioxidant activities. An important feature is the total absence of toxicity. It also improves dysuria by reducing muscle spasm.
Curcumin
Extracted from the rhizome of Curcuma longa, it has an anti-inflammatory action, comparable if not superior to cortisone, inhibiting the production of cytokines (molecules that trigger inflammatory processes at the cellular level).
Cranberry
Traditionally used for urinary tract and bladder infections. Randomized controlled trials support its use specifically as a preventive agent in subjects predisposed to recurrent bladder infections and generally for urinary tract infections. Cranberry acts as a urine acidifier due to its hippuric acid content, but the currently most recognized and accredited activity is due to the presence of proanthocyanidins, which inhibit the adhesion of type P fimbriae of the uropathogenic strains of Escherichia Coli, this activity enhanced by vitamin C, present in Cistiprost, which leads to an enhancement of intravesical acidosis by increasing its antibacterial defenses. The content of Cranberry rich in flavonoids and phenolic acids limits the oxidative and inflammatory processes affecting the vascular endothelium suggesting that these compounds could reduce angiogenesis.
C vitamin
It acts as an antioxidant, fights bacterial infections, promotes the use of energy at the cellular level, promotes the synthesis of noradrenaline, promotes fat burning, neutralizes toxic substances, promoting their elimination and protects the cell membrane from destructive action of free radicals.
Cistiprost, with a combined and synergistic action of its specific components, covered by a patent, intervenes on the antiprostatic, anti-inflammatory, immune, anti-free radicals activity and support for anticancer prevention. It is also an adjuvant to irritation and inflammatory stages of the bladder.

Ingrediants
One tablet contains:
lapacho; lycopene crystals; microcrystalline cellulose; curcumin; cranberry; C vitamin.

How to use
Take 1-2 tablets per day, according to medical opinion, preferably at least one hour before meals.

Warnings
Do not exceed the recommended daily dose.
Keep out of the reach of children under 3 years of age.
Supplements are not intended as a substitute for a varied diet.
For pregnant or lactating women and children it is recommended to seek medical advice.

Format
Pack of 20 tablets.

Cod. EUPH0022.

Bibliography
- Matthias Oelke, Martin C. Michel, What do we really know about benign prostatic hyperplasia and lower urinary tract symptoms in adult men? Hannover Medical School, Germany and University of Amsterdam, World J Urol (2011) 29: 141–142 DOI 10.1007 / s00345-011-0664-5.
- Yallapu MM, Jaggi M, Chauhan SC., Beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. USA. Colloids Surf B Biointerfaces. 2010 Aug 1; 79 (1): 113-25. Epub 2010 Apr 3.
- Marie-Hélène Teiten, François Gaascht, Serge Eifes, Mario Dicato, Marc Diederich, Chemopreventive potential of curcumin in prostate cancer. Luxembourg, Luxembourg Genes Nutr (2010) 5: 61–74 DOI 10.1007 / s12263-009-0152-3.
- N Krzysztof Waliszewski, DSC, Blasco Gabriela, MSc, Nutraceutical properties of lycopene. Mexico Salud Publica Mex vol. 52 n. 3 Cuernavaca May / June 2010.
- Moon DO, Kang CH, Kim MO, Jeon YJ, Lee JD, Choi YH, Kim GY. Beta-lapachone (LAPA) decreases cell viability and telomerase activity in leukemia cells: suppression of telomerase activity by LAPA. Republic of Korea. J Med Food. 2010 Jun; 13 (3): 481-8.
- Daniella Bianchi-Frias, Funda Vakar-Lopez, Ilsa M. Coleman, Stephen R. Plymate, May J. Reed, Peter S. Nelson, The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment. Washington, September 1, 2010.
- GUO Li-jun, TANG Yuan, GUO Chao-ming and ZHANG Xiang-hua, Impact of primary hypertension on hematuria of the patients with benign prostatic hyperplasia. Peking University, Gansu Province People Hospital, Lanzhou, Chin Med J 2010; 123 (9): 1154- 1157.
- Camila B. Piantino, Fernanda A. Salvadori, Pedro P. Ayres, Raphael B. Kato, Victor Srougi, Katia R. Leite, Miguel Srougi, An Evaluation of the Anti-neoplastic Activity of Curcumin in Prostate Cancer Cell Lines. Laboratory of Medical Investigation (CBP, FAS, PPA, RBK, VS, KRL, MS), Sao Paulo, Brazil International Braz J Urol Vol. 35 (3): 354-361, May - June, 2009.
- Lívia L. Corrêa1, Giovanna A. Balarini Lima, Helena B. de Melo Paiva, Cíntia M. dos Santos Silva, Suzana A. Cavallieri, Luiz Carlos D. de Miranda, Mônica R. Gadelha, Prostate cancer and acromegaly. Brasil Arq Bras Endocrinol Metab. 2009; 53 (8): 963-8.
- Marion ET McMurdo1, Ishbel Argo, Gabby Phillips, Fergus Daly and Peter Davey, Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. School, University of Dundee, Scotland, UK Journal of Antimicrobial Chemotherapy (2009) 63, 389–395.
- Wertz K., Lycopene effects contributing to prostate health. DSM Nutritional Products Ltd., Basel, Switzerland Nutr Cancer 2009 Nov; 61 (6): 775-83.
- Chan R, Lok K, Woo J., Prostate cancer and vegetable consumption. Mol Nutr Food Res. 2009 Feb; 53 (2): 201-16.
- Andrzejewski T, Deeb D, Gao X, Danyluk A, Arbab AS, Dulchavsky SA, Gautam SC., Therapeutic efficacy of curcumin / TRAIL combination regimen for hormone-refractory prostate cancer. Department of Surgery, Detroit, MI, USA. Oncol Res. 2008; 17 (6): 257-67.
- Eyong KO, Kumar PS, Kuete V, Folefoc GN, Nkengfack EA, Baskaran S., Semisynthesis and antitumoral activity of 2-acetylfuranonaphthoquinone and other naphthoquinone derivatives from lapachol. Indian Institute of Technology Madras, India. Bioorg Med Chem Lett. 2008 Oct 15; 18 (20): 5387-90. Epub 2008 Sep 17.
- Lien YC, Kung HN, Lu KS, Jeng CJ, Chau YP., Involvement of endoplasmic reticulum stress and activation of MAP kinases in beta-lapachone-induced human prostate cancer cell apoptosis. Taiwan. Histol Histopathol. 2008 Nov; 23 (11): 1299-308.
- Thore Santel, Gabi Pflug, Nasr YA Hemdan, et all., Curcumin Inhibits Glyoxalase 1-A Possible Link to Its Anti-Inflammatory and Anti-Tumor Activity. Institute of Biochemistry, Germany Daniel Tome October 23, 2008.
Jepson RG, Craig JC., Cranberries for preventing urinary tract infections. Cancer Care Research Center Stirling, UK Cochrane Database Syst Rev. 2008 Jan 23 (1): CD001321.
- Ke-Hung Tsui et al., Curcumin Blocks the Activation of Androgen and Interlukin-6 on Prostate-Specific Antigen Expression in Human Prostatic Carcinoma Cells. Department of Urology and the Molecular Image Center Taiwan, Republic of China Jepson RG, Craig JC. , A systematic review of the evidence for cranberries and blueberries in UTI prevention. University of Stirling, UK Mol Nutr Food Res. 2007 Jun; 51 (6): 738-45.
- Catherine C., Neto Cranberry and Its Phytochemicals: A Review of In Vitro Anticancer Studies. University of Massachusetts – Dartmouth J. Nutr. 137: 186S – 193S, 2007.
- Salman H, Bergman M, Djaldetti M, Bessler H., Lycopene affects proliferation and apoptosis of four malignant cell lines. Tel-Aviv University, Ramat-Aviv, Israel. Biomed Pharmacother. 2007 Jul; 61 (6): 366-9. Epub 2007 Mar 19.
- Sharmila Shankar and Rakesh K. Srivastava, Involvement of Bcl-2 family members, phosphatidylinositol 3-kinase / AKT and mitochondrial p53 in curcumin (diferulolylmethane) - induced apoptosis in prostate cancer. University of texas Health Center, Tyler International Journal of Oncology 30: 905-918, 2007.
- Kim SO, Kwon JI, Jeong YK, Kim ND, Choi YH, Lapacho tree (Tabebuia avallanedae) anti-inflammatory and anti-cancer activities. Dongeui University College of Oriental Medicine. Biosci Biochem. 2007 Sep; 71 (9): 2196-76 2007 Sep. 7.
- Liu Y, Black MA, Caron L, Camesano TA., Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli. Worcester Polytechnic Institute Biotechnol Bioeng. 2006 Feb 5; 93 (2): 297-305.
- Edward H. Oswald, Descriptive, analytical and activity report of the “Lapacho-Tabebuia”. From British Journal of Phytotherapy, vol. 3 n. 3, 1993/1994.
- Ammon HP, Safayhi H, Mack T, Sabieraj J., Mechanism of antiinflammatory actions of curcumine and boswellic acids. Department of Pharmacology, Tübingen, FRG. J Ethnopharmacol. 1993 Mar; 38 (2-3): 113-9.
- Oga S. and Sekino T, Toxicidade and atividade anti-inflamatoria de Tabebuia Avell. Lorentz and Griesbach. Rev Fac Farm Bioquim S. Paulo 7, 47-53, 1969.